Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATE-RA: Faster Rituximab Infusion in RA
NCT01382940Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2011
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Jul 2011; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01382940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382940.